Formidable Asset Management, LLC Gilead Sciences, Inc. Transaction History

Formidable Asset Management, LLC

$609 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $128,414 - $156,598	1,794 New	1,794 $131,000
Q4 2022 Feb 07, 2023	SELL	$62.32 - $89.47 $79,458 - $114,074	-1,275 Reduced 31.44%	2,780 $239,000
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $2,381 - $2,720	-40 Reduced 0.98%	4,055 $283,000
Q2 2022 Aug 16, 2022	SELL	$57.72 - $65.01 $11,717 - $13,197	-203 Reduced 4.72%	4,095 $253,000
Q1 2022 May 04, 2022	SELL	$57.92 - $72.58 $36,663 - $45,943	-633 Reduced 12.84%	4,298 $256,000
Q4 2021 Feb 07, 2022	BUY	$64.88 - $73.64 $1,622 - $1,841	25 Added 0.51%	4,931 $357,000
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $113,313 - $122,252	1,674 Added 51.79%	4,906 $343,000
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $196,185 - $214,360	3,091 Added 2192.2%	3,232 $222,000
Q2 2021 Aug 06, 2021	SELL	$63.47 - $69.35 $318,302 - $347,790	-5,015 Reduced 97.27%	141 $246,000
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $6,780 - $7,735	113 Added 2.24%	5,156 $342,000
Q4 2020 Jan 29, 2021	BUY	$56.65 - $64.55 $38,805 - $44,216	685 Added 15.72%	5,043 $300,000
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $17,201 - $21,628	277 Added 6.79%	4,358 $271,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $72,340 - $84,000	-1,000 Reduced 19.68%	4,081 $313,000
Q1 2020 Jun 01, 2020	BUY	$62.63 - $80.22 $99,268 - $127,148	1,585 Added 45.34%	5,081 $380,000
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $215,423 - $236,958	3,496 New	3,496 $219,000
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $221,973 - $245,019	-3,551 Closed	0 $0
Q2 2019 Oct 15, 2019	BUY	$61.87 - $69.38 $219,700 - $246,368	3,551 New	3,551 $233,000
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $309,644 - $363,479	-4,352 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $313,822 - $371,965	4,352	4,352 $353,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Formidable Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Formidable Asset Management, LLC with notifications on news.

Account